72. 下垂体性ADH分泌異常症 Pituitary ADH secretion disorder Clinical trials / Disease details


臨床試験数 : 41 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04789148
(ClinicalTrials.gov)
June 20235/3/2021Effects of Intranasal Oxytocin in Patients With Central Diabetes InsipidusEffects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot StudyCentral Diabetes InsipidusDrug: Oxytocin nasal sprayElizabeth Austen LawsonNULLNot yet recruiting18 Years60 YearsAll30Phase 1United States
2NCT05319301
(ClinicalTrials.gov)
April 1, 202217/3/2022Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)Identification and Clinical Relevance of an Oxytocin Deficient State Following Melatonin Administration in Patients With Hypopituitarism: a Proof-of-concept, Physiopathological Study With a Control GroupOxytocin Deficiency;Hypopituitarism;Hypothalamic Obesity;Pituitary Dysfunction;Central Diabetes Insipidus;Social IsolationDietary Supplement: MelatoninFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNULLNot yet recruiting18 YearsN/AAll40N/ASpain
3NCT04897802
(ClinicalTrials.gov)
September 13, 202117/5/2021Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)Identification and Clinical Relevance of an Oxytocin Deficient State: a Randomized, Crossover, Placebo-controlled, Proof-of-concept, Physiopathological Study (GLP1 Study)Hypopituitarism;Central Diabetes Insipidus;Panhypopituitarism;Psychological Disorder;Social Isolation;Hypothalamic Diseases;Pituitary Diseases;Oxytocin DeficiencyDrug: Experimental: GLP1-RA (exenatide) administration;Drug: Control: Placebo administrationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauInstituto de Salud Carlos IIIRecruiting18 Years65 YearsAll52Phase 4Spain
4NCT04902235
(ClinicalTrials.gov)
July 6, 202117/5/2021Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)Identification and Clinical Relevance of an Oxytocin Deficient State: a Randomized, Crossover, Placebo-controlled, Proof-of-concept Physiopathological Study (CRH Study)Hypopituitarism;Central Diabetes Insipidus;Panhypopituitarism;Psychological Disorder;Social Isolation;Hypothalamic Diseases;Pituitary Diseases;Oxytocin DeficiencyDrug: Experimental: CRH administration;Drug: Control: Placebo administrationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauInstituto de Salud Carlos IIIRecruiting18 Years65 YearsAll52Phase 4Spain